Detalhe da pesquisa
1.
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.
Cancer Cell;
42(4): 623-645.e10, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490212
2.
Heterogeneity in functional genetic screens: friend or foe?
Front Immunol;
14: 1162706, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398651
3.
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Nat Commun;
14(1): 672, 2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750559
4.
An adverse tumor-protective effect of IDO1 inhibition.
Cell Rep Med;
4(2): 100941, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36812891
5.
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling.
EMBO J;
42(5): e111614, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715448
6.
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells.
Cell Rep Med;
3(6): 100655, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688159
7.
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.
Nat Commun;
13(1): 1923, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395848
8.
Enabling oncogenes.
Science;
373(6559): 1088-1089, 2021 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516853
9.
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.
Clin Cancer Res;
27(19): 5389-5400, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230026
10.
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.
Cancer Res;
81(7): 1775-1787, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531370
11.
Labeling and tracking of immune cells in ex vivo human skin.
Nat Protoc;
16(2): 791-811, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33349704
12.
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.
Nat Commun;
11(1): 3946, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770055
13.
A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool.
J Exp Med;
217(10)2020 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728699
14.
Author Correction: Tissue patrol by resident memory CD8+ T cells in human skin.
Nat Immunol;
21(6): 696, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32210390
15.
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Cell;
180(2): 404-405, 2020 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978349
16.
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma.
Pigment Cell Melanoma Res;
33(2): 334-344, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549767
17.
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Cell;
178(3): 585-599.e15, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31303383
18.
Tissue patrol by resident memory CD8+ T cells in human skin.
Nat Immunol;
20(6): 756-764, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31110315
19.
In vitro-Induced Human IL-10+ B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory Cytokines.
Front Immunol;
9: 1913, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258433
20.
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
Nat Med;
24(2): 203-212, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29334371